Evolution and improved outcomes in the era of multimodality treatment for extended pancreatectomy
Open Access
- 2 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 8 (4)
Abstract
The evolution and outcomes of extended pancreatectomies at a single institute over 15 years are presented in this study. A retrospective analysis of the institutional database was performed from 2015 to 2022 (period B). Patients undergoing extended pancreatic resections, as defined by the International Study Group for Pancreatic Surgery, were included. Perioperative and survival outcomes were compared with data from 2007–2015 (period A). Regression analyses were used to identify factors affecting postoperative and long-term survival outcomes. A total of 197 (16.1%) patients underwent an extended resection in period B compared to 63 (9.2%) in period A. Higher proportions of borderline resectable (5 (18.5%) versus 51 (47.7%), P = 0.011) and locally advanced tumours (1 (3.7%) versus 24 (22.4%), P < 0.001) were resected in period B with more frequent use of neoadjuvant therapy (6 (22.2%) versus 79 (73.8%), P < 0.001). Perioperative mortality (4 (6.0%) versus 12 (6.1%), P = 0.81) and morbidity (23 (36.5%) versus 83 (42.1%), P = 0.57) rates were comparable. The overall survival for patients with pancreatic adenocarcinoma was similar in both periods (17.5 (95% c.i. 6.77 to 28.22) versus 18.3 (95% c.i. 7.91 to 28.68) months, P = 0.958). Resectable, node-positive tumours had a longer disease-free survival (DFS) in period B (5.81 (95% c.i. 1.73 to 9.89) versus 14.03 (95% c.i. 5.7 to 22.35) months, P = 0.018). Increasingly complex pancreatic resections were performed with consistent perioperative outcomes and improved DFS compared to the earlier period. A graduated approach to escalating surgical complexity, multimodality treatment, and judicious patient selection enables the resection of advanced pancreatic tumours.Keywords
This publication has 51 references indexed in Scilit:
- Short‐term outcomes after vascular resection for pancreatic tumors: Lessons learned from 72 cases from a single Brazilian Cancer CenterJournal of Surgical Oncology, 2019
- Twelve Hundred Consecutive Pancreato‐Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Cancer Surgery Across IndiaWorld Journal of Surgery, 2019
- The Clavien–Dindo Classification of Surgical Complications2013
- Pancreatectomy Combined with Superior Mesenteric Vein–Portal Vein Resection for Pancreatic Cancer: A Meta‐analysisWorld Journal of Surgery, 2012
- Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intentCancer, 2011
- Superior mesenteric artery first combined with uncinate process approach versus uncinate process first approach in pancreatoduodenectomy: a comparative study evaluating perioperative outcomesLangenbeck's Archives of Surgery, 2011
- Extended Appleby's operation for pancreatic cancer involving celiac axisJournal of Surgical Oncology, 2007
- Redefining the R1 resection in pancreatic cancerBritish Journal of Surgery, 2006
- Evaluation of the Complication Rate as a Measure of Quality of Care in Coronary Artery Bypass Graft SurgeryJAMA, 1995
- Combined resection of the pancreas and portal vein for pancreatic cancerBritish Journal of Surgery, 1994